Gubra A/S

Common Name
Gubra
Country
Denmark
Sector
Healthcare
Industry
Biotechnology
Employees
260
Ticker
GUBRA
Exchange
NASDAQ COPENHAGEN A/S
Description
Gubra A/S is a biotechnology company focused on the development and discovery of peptide-based therapies targeting metabolic, fibrotic, and gastrointestinal diseases. As a key player in the biotech se...

Gubra's GHG Emissions Data Preview

In 2023, Gubra completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Gubra has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Gubra’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gubra’s data sources below and access millions more through our Disclosure Search.

a. Gubra's Annual Report 2023
a. Gubra's Annual Report 2023

Insights into Gubra's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Gubra amounted to 172.35 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Gubra increased by 63.16%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Gubra's Scope 1 Emissions Over Time

2022202302468tCO2e+500%
  • Total Scope 1
  • Year-over-Year Change

What are Gubra's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Gubra were 6 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2022), Gubra's Scope 1 emissions increased by 500%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Gubra's Scope 2 emissions?

In 2023, Gubra reported Scope 2 greenhouse gas (GHG) emissions of 166.35 tCO₂e using the market-based method. a

Has Gubra reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Gubra's Scope 2 emissions (Market-Based) rose by 58.99% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Gubra use for Scope 2 reporting?

In 2023, Gubra reported its Scope 2 emissions using the market-based method. a

Gubra's Scope 2 Emissions Over Time

2022202304590135180tCO2e
  • Total Scope 2 Market-Based

Insights into Gubra's Value Chain Emissions

In 2023, Gubra reported 409.13 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2023 disclosure of Gubra includes a breakdown across 6 of the 15 Scope 3 categories defined by the GHG Protocol, up from 5 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Gubra's Scope 3 Emissions Over Time

202220230150300450600tCO2e+42%
  • Total Scope 3
  • Year-over-Year Change

What are Gubra's Scope 3 emissions?

In 2023, Gubra reported total Scope 3 emissions of 409.13 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a

Compared to the previous year (2022), Gubra's Scope 3 emissions increased by 41.83%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Gubra disclose?

In 2023, Gubra reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Gubra's Scope 3 emissions?

In 2023, the largest contributors to Gubra's Scope 3 emissions were: a

  • Employee Commuting (Cat. 7): 227.64 tCO₂e (55.64%)
  • Business Travel (Cat. 6): 60.6 tCO₂e (14.81%)
  • Fuel- and Energy-Related Services (Cat. 3): 52.52 tCO₂e (12.84%)

Gubra's Scope 3 Emissions by Categories

Employee Commuting(Cat. 7)(55.6%)Fuel- andEnergy-RelatedServices (Cat. 3)(12.8%)Business Travel(Cat. 6)(14.8%)

Insights into Gubra’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Gubra reported Scope 1 greenhouse gas (GHG) emissions of 6 tCO₂e and total revenues of USD 30 millions. This translates into an emissions intensity of 0.2 tCO₂e per millions USD. a

Gubra's Scope 1 Emissions Intensity Compared to Peers

5501,00010,000100,000Scope 1 Emissions (tCO2e)5505005,000100,000Revenues (Millions of USD)ASGenmabYear: 2024Scope 1: 534 tCO2eRevenue: $M 3,003Scope 1 Intensity: 0.18 tCO2e/$MInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MPharma MarYear: 2023Scope 1: 1,233 tCO2eRevenue: $M 175Scope 1 Intensity: 7.04 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MIdorsiaYear: 2024Scope 1: 733 tCO2eRevenue: $M 124Scope 1 Intensity: 5.90 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MBavarian NordicYear: 2023Scope 1: 4,364 tCO2eRevenue: $M 1,046Scope 1 Intensity: 4.17 tCO2e/$MALK-AbelloYear: 2023Scope 1: 10,256 tCO2eRevenue: $M 714Scope 1 Intensity: 14.36 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MAscendis PharmaYear: 2024Scope 1: 62 tCO2eRevenue: $M 443Scope 1 Intensity: 0.14 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MCamurusYear: 2024Scope 1: 116 tCO2eRevenue: $M 169Scope 1 Intensity: 0.68 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MBeOne MedicinesYear: 2024Scope 1: 3,547 tCO2eRevenue: $M 27,369Scope 1 Intensity: 0.13 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MValnevaYear: 2024Scope 1: 1,277 tCO2eRevenue: $M 176Scope 1 Intensity: 7.24 tCO2e/$MZealand PharmaYear: 2024Scope 1: 145 tCO2eRevenue: $M 9Scope 1 Intensity: 16.60 tCO2e/$MGubraYear: 2023Scope 1: 6 tCO2eRevenue: $M 30Scope 1 Intensity: 0.20 tCO2e/$M

How does Gubra's GHG emissions intensity compare to its peers?

In 2023, Gubra reported a Scope 1 emissions intensity of 0.2 tCO₂e per millions USD. Compared to the peer group median of 5.24 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Gubra rank on GHG emissions intensity within its industry?

In 2023, Gubra ranked 5 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Gubra among the top performers, with one of the lowest emissions intensities relative to peers. a

Insights into Gubra's Total Carbon Footprint

In 2023, Gubra reported a total carbon footprint of 581.48 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 47.55% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Gubra's total carbon footprint was Scope 3 emissions, accounting for 70.36% of the company's total carbon footprint, followed by Scope 2 emissions at 28.61%. a

Want Full Access to Gubra's GHG Emissions Dataset?
Sign Up